Navigation Links
FDA Accepts Genta's NDA Amendment as Complete Response for Genasense(R) Treatment of Chronic Lymphocytic Leukemia
Date:7/14/2008

Submission Based on Increased 5-Year Survival in Responding Patients

BERKELEY HEIGHTS, N.J., July 14 /PRNewswire-FirstCall/ -- Genta Incorporated (OTC Bulletin Board: GNTA) announced that the Food and Drug Administration (FDA) has accepted the Company's amendment to its New Drug Application (NDA) for Genasense(R) (oblimersen sodium) Injection as a "complete response". The NDA proposed the use of Genasense plus chemotherapy for patients with relapsed or refractory chronic lymphocytic leukemia (CLL). The recent submission was based on new information from the Company's completed, randomized Phase 3 trial that showed, among other findings, a significant increase in overall survival for patients who achieved a complete or partial response when treated with Genasense plus chemotherapy compared with patients treated with chemotherapy alone.

The amendment responds to a communication received in March 2008 from FDA's Center for Drug Evaluation and Research (CDER) that denied Genta's appeal of a prior "non-approvable" decision of the Genasense NDA in December 2006. That communication described a regulatory path forward that included but was not limited to determination of long-term survival in patients who entered the study. FDA has informed the Company that it considers Genta's complete response as a Class 2 resubmission with a Prescription Drug User Fee Act (PDUFA) goal date of December 3, 2008.

"We are pleased that the FDA will formally review this new information, and we look forward to working with FDA's Division of Oncology Drug Products during their consideration of this amendment," commented Dr. Loretta M. Itri, Genta's President, Pharmaceutical Development, and Chief Medical Officer.

About Chronic Lymphocytic Leukemia

CLL is the most common form of leukemia in adults. According to the American Cancer Society, approximately 8,000 patients will be diagnosed this year. More than 60,000 people in the U.S. currently have CLL. The
'/>"/>

SOURCE Genta Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Partnering With MyPyramid: NUTRIKIDS Accepts the Challenge to Help Families Step Up to Healthier Living
2. AMEX Accepts Lorus Plan to Meet AMEXs Continued Listing Standards
3. Mike Huckabee Accepts Values Voter Presidential Debate
4. ev3 Inc. Accepts Resignation of Dr. John Simpson
5. Lieutenant Governor Catherine Baker Knoll Accepts Women in Government Presidential Leadership Award
6. FDA Accepts New Drug Application for NEBIDO(R) Submitted by Indevus
7. Governor Rendell Accepts National Health Care Reform Pioneer Award
8. American Stock Exchange Accepts Encisions Plan to Regain Compliance
9. FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
10. FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
11. Nuvo Research and Paladin announce amendments to Pennsaid and Pennsaid Plus agreements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2015)... ... 01, 2015 , ... The condition where veins are enlarged and gnarled is ... pain and discomfort. Those who spend a lot of time on their feet and ... is doing what it can to create awareness and provide a cure in observance ...
(Date:8/1/2015)... ... August 01, 2015 , ... On Tuesday, July 28th, Symantec released a security ... have been behind the attack on Anthem Inc. which resulted in one of the ... hole attacks and spear phishing campaigns. , For Joe Caruso, founder and ...
(Date:7/31/2015)... ... July 31, 2015 , ... That’s right, ... are the STASH awards? The Significant Technological Achievements in Secretive Horticulture (or STASH) ... well as tried-and-true products that have stood the test of time. These include ...
(Date:7/31/2015)... Chicago, IL (PRWEB) , ... July 31, 2015 , ... ... which is currently going on in Chicago at Grant Park. The festival ... every corner of North America to Chicago for the annual Lollapalooza. This unique ...
(Date:7/31/2015)... ... ... Sculpted Contours Luxury Medical Aesthetics announces the arrival of the newest applicator ... new applicator in the United States as an upgrade to the CoolSmooth applicator cleared ... applicator required a 2 hour treatment time. The new CoolSmooth Pro reduces the ...
Breaking Medicine News(10 mins):Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 2Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 4Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 3
... health will be presented in Denver April 30-May 3, as ... (PAS). This year,s gathering is a joint meeting with the ... leaders in academic pediatrics from around the world are expected ... Journalists will have access to hundreds of scientists who ...
... a tight spot, the cell cycle regulator p21 halts ... damage, or if all else fails, to initiate programmed ... dispense with the regular transcriptional entourage, p21Cip1 still requires ... the editing of transcripts, to be expressed, found researchers ...
... FRIDAY, April 1 (HealthDay News) -- More than one-quarter of ... have had children with different men, a new study shows. ... nearly 4,000 women who were past their child-bearing years and ... as part of the National Longitudinal Survey of Youth. ...
... bag: PUMA contributes to ulcerative colitis Ulcerative ... be related to aberrant activation of the immune system ... regulated cell death (apoptosis) of the intestinal epithelial cells ... molecular mechanisms that control the cellular response to inflammation ...
... get their information about vaccines from their children,s doctors, ... friends and family members and even celebrities as sources ... a national survey conducted by University of Michigan researchers ... information in regards to vaccines, as well as to ...
... too late in children and adolescents. In the current ... Int 2011; 108: 173-79), Susanne Walitza and her colleagues ... positively affect the course of the disease. Compulsive ... adolescents, is present in up to 87% of all ...
Cached Medicine News:Health News:Children's health is focus of annual meeting of Pediatric Academic Societies 2Health News:'SKIP'-ing splicing forces tumor cells to undergo programmed cell death 2Health News:'SKIP'-ing splicing forces tumor cells to undergo programmed cell death 3Health News:Many Moms Have Kids With Different Dads, U.S. Study Finds 2Health News:JCI online early table of contents: April 1, 2011 2Health News:JCI online early table of contents: April 1, 2011 3Health News:JCI online early table of contents: April 1, 2011 4Health News:JCI online early table of contents: April 1, 2011 5Health News:JCI online early table of contents: April 1, 2011 6Health News:JCI online early table of contents: April 1, 2011 7Health News:JCI online early table of contents: April 1, 2011 8Health News:JCI online early table of contents: April 1, 2011 9Health News:JCI online early table of contents: April 1, 2011 10Health News:JCI online early table of contents: April 1, 2011 11Health News:U-M experts: Parents trust doctors most when it comes to information about vaccine safety 2
(Date:7/31/2015)... July 31, 2015  Semler Scientific, Inc. (Nasdaq: ... services to healthcare insurers and physician groups, today reported ... 2015. "In the second quarter of ... revenue growth of 54%, quarter over quarter revenue growth ... installed base of FloChec® units of 18%," said Doug ...
(Date:7/31/2015)... , July 31, 2015 According ... Market by Product (Bioimpedance Analyzers (BIA), Dual-Energy X-ray Absorptiometry ... Weighing) - Global Analysis & Forecast to 2019", published ... pegged at $911.1 Million 2014 and is estimated to ... CAGR of 9.4% from 2014 to 2019. ...
(Date:7/30/2015)... 2015 Mettler-Toledo International Inc. (NYSE: MTD ... below are the highlights: , Sales in ... the prior year. Reported sales decreased 4% as currency ... , Net earnings per diluted share as reported (EPS) ... Adjusted EPS was $2.80 , an increase of ...
Breaking Medicine Technology:Semler Reports Second Quarter 2015 Financial Results 2Semler Reports Second Quarter 2015 Financial Results 3Semler Reports Second Quarter 2015 Financial Results 4Semler Reports Second Quarter 2015 Financial Results 5Semler Reports Second Quarter 2015 Financial Results 6Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 14
... , Company expects to meet or exceed 2011 EPS ... declines due to Zyprexa patent expiration. , 2012 revenue ... Company expects to keep 2012 operating expenses essentially flat versus 2011. ... the range of $3.10 - $3.20. , R&D pipeline ...
... January 5, 2012 Predator Nutrition, one of ... burners and creatine , raised £762 and invaluable ... football tournament in Leeds in December. The sports ... made up of business partners and close friends and family ...
Cached Medicine Technology:Lilly Comments on 2011 Financial Guidance and Announces 2012 Financial Guidance 2Lilly Comments on 2011 Financial Guidance and Announces 2012 Financial Guidance 3Lilly Comments on 2011 Financial Guidance and Announces 2012 Financial Guidance 4Lilly Comments on 2011 Financial Guidance and Announces 2012 Financial Guidance 5Predator Nutrition Tackles Africa in Charity Football Tournament 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: